Shuying Shen

10PUBLICATIONS
33CO-AUTHORS
Haematological tumoursOrthopticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer cell biologyMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 10, 2026
Chondrocytes reprogram chromatin in hypoxic microenvironments to activate CADM1-AS1/HDAC1 complex-mediated anti-inflammation signals.

Weiyu Ni, Tianyuan Gu, Panyang Shen

|Oct 01, 2025
ZDHHC11-mediated palmitoylation alleviates chondrocyte senescence and serves as a therapeutic target for osteoarthritis.

Kefan Wang, Wei He, Zhe Gong

|Mar 26, 2025
TRIM15 drives chondrocyte senescence and osteoarthritis progression.

Zhuang Li, Weituo Zhang, Xiao Ying Wei

|Mar 11, 2025
Interleukin-16 enhances anti-tumor immune responses by establishing a Th1 cell-macrophage crosstalk through reprogramming glutamine metabolism in mice.

Zhenzhen Wen, Tong Liu, Xutao Xu

|Aug 28, 2023
CircRREB1 mediates lipid metabolism related senescent phenotypes in chondrocytes through FASN post-translational modifications.

Zhe Gong, Jinjin Zhu, Junxin Chen

|Feb 08, 2023
Metabolite asymmetric dimethylarginine (ADMA) functions as a destabilization enhancer of SOX9 mediated by DDAH1 in osteoarthritis.

Yizheng Wu, Shuying Shen, Jiaxin Chen

Pageof 2

Frequent Collaborators

3 joint publications

Shunwu Fan

2 joint publications

Junjie Chu

2 joint publications

Mingliang Ji

2 joint publications

Xiangqian Fang